Proteomic profiling distinguishes astrocytomas and identifies differential tumor markers.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 16534112.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Methods to permit more precise delineation of astrocytomas of different grades may have therapeutic utility. The authors selectively microdissected pure populations of cells from normal brain and astrocytomas. They performed two-dimensional protein gel electrophoresis (2DGE) followed by protein sequencing. Differential expression was confirmed immunohistochemically. 2DGE identified proteomic patterns and proteins that differentiated normal brain from tumor and distinguished astrocytomas of increasing grade.
Medical subject headings
- Astrocytoma
- Biomarkers, Tumor
- Brain Neoplasms
- Protein Array Analysis